{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:26:07Z","timestamp":1790429167074,"version":"4.1.0"},"reference-count":50,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"IMI2-JU","award":["115797"],"award-info":[{"award-number":["115797"]}]},{"name":"IMI2-JU","award":["945268"],"award-info":[{"award-number":["945268"]}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C16\/18\/006"],"award-info":[{"award-number":["C16\/18\/006"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11A0220N"],"award-info":[{"award-number":["11A0220N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11Y6716N"],"award-info":[{"award-number":["11Y6716N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1189518N"],"award-info":[{"award-number":["1189518N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12R0719N"],"award-info":[{"award-number":["12R0719N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35-GM-118112"],"award-info":[{"award-number":["R35-GM-118112"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:p>Protein citrullination plays a role in several autoimmune diseases. Its involvement in murine and human type 1 diabetes has recently been recognized through the discovery of antibodies and T-cell reactivity against citrullinated peptides. In the current study, we demonstrate that systemic inhibition of peptidylarginine deiminases (PADs), the enzymes mediating citrullination, through BB-Cl-amidine treatment, prevents diabetes development in NOD mice. This prevention was associated with reduced levels of citrullination in the pancreas, decreased circulating autoantibody titers against citrullinated glucose-regulated protein 78, and reduced spontaneous neutrophil extracellular trap formation of bone marrow\u2013derived neutrophils. Moreover, BB-Cl-amidine treatment induced a shift from Th1 to Th2 cytokines in the serum and an increase in the frequency of regulatory T cells in the blood and spleen. In the pancreas, BB-Cl-amidine treatment preserved insulin production and was associated with a less destructive immune infiltrate characterized by reduced frequencies of effector memory CD4+ T cells and a modest reduction in the frequency of interferon-\u03b3\u2013producing CD4+ and CD8+ T cells. Our results point to a role of citrullination in the pathogenesis of autoimmune diabetes, with PAD inhibition leading to disease prevention through modulation of immune pathways. These findings provide insight in the potential of PAD inhibition for treating autoimmune diseases like type 1 diabetes.<\/jats:p>","DOI":"10.2337\/db20-0421","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T04:36:03Z","timestamp":1605674163000},"page":"516-528","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":43,"title":["Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice"],"prefix":"10.2337","volume":"70","author":[{"given":"Fernanda M.C.","family":"Sodr\u00e9","sequence":"first","affiliation":[{"name":"Laboratory for Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samal","family":"Bissenova","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylke","family":"Bruggeman","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Tilvawala","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA"},{"name":"Department of Molecular Biosciences, The University of Kansas, Lawrence, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana P.","family":"Cook","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Berthault","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Cochin, CNRS, INSERM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Mondal","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00efsha","family":"Callebaut","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvaine","family":"You","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Cochin, CNRS, INSERM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-337X","authenticated-orcid":false,"given":"Raphael","family":"Scharfmann","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Cochin, CNRS, INSERM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9846-8861","authenticated-orcid":false,"given":"Roberto","family":"Mallone","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Institut Cochin, CNRS, INSERM, Paris, France"},{"name":"Assistance Publique H\u00f4pitaux de Paris, H\u00f4pitaux Universitaires de Paris Centre-Universit\u00e9 de Paris, Cochin Hospital, Service de Diab\u00e9tologie et Immunologie Clinique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6099-2406","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4202-2473","authenticated-orcid":false,"given":"Mijke","family":"Buitinga","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-356X","authenticated-orcid":false,"given":"Lut","family":"Overbergh","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"2022031303024320000_B1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1084\/jem.20051251","article-title":"The insulin A-chain epitope recognized by human T cells is posttranslationally modified","volume":"202","author":"Mannering","year":"2005","journal-title":"J Exp Med"},{"key":"2022031303024320000_B2","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.2337\/db12-0112","article-title":"Diabetogenic T-cell clones recognize an altered peptide of chromogranin A","volume":"61","author":"Delong","year":"2012","journal-title":"Diabetes"},{"key":"2022031303024320000_B3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2337\/db12-1214","article-title":"Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes","volume":"63","author":"van Lummel","year":"2014","journal-title":"Diabetes"},{"key":"2022031303024320000_B4","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.2337\/db13-1952","article-title":"Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes","volume":"63","author":"McGinty","year":"2014","journal-title":"Diabetes"},{"key":"2022031303024320000_B5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2337\/db14-0621","article-title":"Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes","volume":"64","author":"Rondas","year":"2015","journal-title":"Diabetes"},{"key":"2022031303024320000_B6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/nm.4203","article-title":"Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes","volume":"22","author":"Babon","year":"2016","journal-title":"Nat Med"},{"key":"2022031303024320000_B7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00125-017-4296-1","article-title":"Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children","volume":"60","author":"Strollo","year":"2017","journal-title":"Diabetologia"},{"key":"2022031303024320000_B8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/db17-1166","article-title":"Modifying enzymes are elicited by ER stress, generating epitopes that are selectively recognized by CD4+ T cells in patients with type 1 diabetes","volume":"67","author":"Marre","year":"2018","journal-title":"Diabetes"},{"key":"2022031303024320000_B9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmet.2018.07.007","article-title":"Conventional and neo-antigenic peptides presented by \u03b2 cells are targeted by circulating na\u00efve CD8+ T cells in type 1 diabetic and healthy donors","volume":"28","author":"Gonzalez-Duque","year":"2018","journal-title":"Cell Metab"},{"key":"2022031303024320000_B10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2337\/db18-0295","article-title":"Inflammation-induced citrullinated glucose-regulated protein 78 elicits immune responses in human type 1 diabetes","volume":"67","author":"Buitinga","year":"2018","journal-title":"Diabetes"},{"key":"2022031303024320000_B11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1389450116666150202160954","article-title":"Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation","volume":"16","author":"Witalison","year":"2015","journal-title":"Curr Drug Targets"},{"key":"2022031303024320000_B12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/imm.12640","article-title":"Immune recognition of citrullinated epitopes","volume":"149","author":"Nguyen","year":"2016","journal-title":"Immunology"},{"key":"2022031303024320000_B13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11892-015-0657-7","article-title":"T cell epitopes and post-translationally modified epitopes in type 1 diabetes","volume":"15","author":"McGinty","year":"2015","journal-title":"Curr Diab Rep"},{"key":"2022031303024320000_B14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41419-019-1518-0","article-title":"Cytokine-induced translocation of GRP78 to the plasma membrane triggers a pro-apoptotic feedback loop in pancreatic beta cells","volume":"10","author":"Vig","year":"2019","journal-title":"Cell Death Dis"},{"key":"2022031303024320000_B15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3389\/fimmu.2017.01200","article-title":"Spontaneous secretion of the citrullination enzyme PAD2 and cell surface exposure of PAD4 by neutrophils","volume":"8","author":"Zhou","year":"2017","journal-title":"Front Immunol"},{"key":"2022031303024320000_B16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00125-016-4191-1","article-title":"Early differences in islets from prediabetic NOD mice: combined microarray and proteomic analysis","volume":"60","author":"Cr\u00e8vecoeur","year":"2017","journal-title":"Diabetologia"},{"key":"2022031303024320000_B17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat Med"},{"key":"2022031303024320000_B18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/1753-0407.12892","article-title":"Increased formation of neutrophil extracellular traps is associated with gut leakage in patients with type 1 but not type 2 diabetes","volume":"11","author":"You","year":"2019","journal-title":"J Diabetes"},{"key":"2022031303024320000_B19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.200806072","article-title":"Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation","volume":"184","author":"Wang","year":"2009","journal-title":"J Cell Biol"},{"key":"2022031303024320000_B20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nm.3042","article-title":"Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes","volume":"19","author":"Diana","year":"2013","journal-title":"Nat Med"},{"key":"2022031303024320000_B21","doi-asserted-by":"crossref","first-page":"e122146","DOI":"10.1172\/jci.insight.122146","article-title":"Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes","volume":"3","author":"Vecchio","year":"2018","journal-title":"JCI Insight"},{"key":"2022031303024320000_B22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/db14-0443","article-title":"CXCR1\/2 inhibition blocks and reverses type 1 diabetes in mice","volume":"64","author":"Citro","year":"2015","journal-title":"Diabetes"},{"key":"2022031303024320000_B23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.lfs.2019.02.034","article-title":"Ameliorating gut microenvironment through staphylococcal nuclease-mediated intestinal NETs degradation for prevention of type 1 diabetes in NOD mice","volume":"221","author":"Liang","year":"2019","journal-title":"Life Sci"},{"key":"2022031303024320000_B24","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1042\/CS20200021","article-title":"Neutrophil elastase triggers the development of autoimmune diabetes by exacerbating innate immune responses in pancreatic islets of non-obese diabetic mice","volume":"134","author":"Shu","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"2022031303024320000_B25","first-page":"7592851","article-title":"An overview of the intrinsic role of citrullination in autoimmune disorders","volume-title":"J Immunol Res","author":"Alghamdi","year":"2019"},{"key":"2022031303024320000_B26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/14397595.2018.1532545","article-title":"Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6","volume":"29","author":"Kawaguchi","year":"2019","journal-title":"Mod Rheumatol"},{"key":"2022031303024320000_B27","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00435.2010","article-title":"Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor","volume":"300","author":"Chumanevich","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022031303024320000_B28","doi-asserted-by":"crossref","first-page":"36053","DOI":"10.18632\/oncotarget.5937","article-title":"Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer","volume":"6","author":"Witalison","year":"2015","journal-title":"Oncotarget"},{"key":"2022031303024320000_B29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.18632\/oncotarget.13894","article-title":"Looking for the best anti-colitis medicine: a comparative analysis of current and prospective compounds","volume":"8","author":"Chumanevich","year":"2017","journal-title":"Oncotarget"},{"key":"2022031303024320000_B30","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1172\/JCI67390","article-title":"Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus","volume":"123","author":"Knight","year":"2013","journal-title":"J Clin Invest"},{"key":"2022031303024320000_B31","doi-asserted-by":"crossref","first-page":"26430","DOI":"10.1038\/srep26430","article-title":"Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses","volume":"6","author":"Kawalkowska","year":"2016","journal-title":"Sci Rep"},{"key":"2022031303024320000_B32","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.4049\/jimmunol.1001620","article-title":"N-\u03b1-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis","volume":"186","author":"Willis","year":"2011","journal-title":"J Immunol"},{"key":"2022031303024320000_B33","first-page":"467","article-title":"Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis","volume":"6","author":"Moscarello","year":"2013","journal-title":"Dis Model Mech"},{"key":"2022031303024320000_B34","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","article-title":"Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice","volume":"74","author":"Knight","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022031303024320000_B35","doi-asserted-by":"crossref","first-page":"11850","DOI":"10.1002\/jcp.27874","article-title":"Targeting peptidylarginine deiminase reduces neutrophil extracellular trap formation and tissue injury in severe acute pancreatitis","volume":"234","author":"Madhi","year":"2019","journal-title":"J Cell Physiol"},{"key":"2022031303024320000_B36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000448808","article-title":"Cl-amidine prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model","volume":"9","author":"Biron","year":"2018","journal-title":"J Innate Immun"},{"key":"2022031303024320000_B37","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/eji.201646542","article-title":"Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation","volume":"46","author":"Papadaki","year":"2016","journal-title":"Eur J Immunol"},{"key":"2022031303024320000_B38","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1021\/bi061180d","article-title":"Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization","volume":"45","author":"Luo","year":"2006","journal-title":"Biochemistry"},{"key":"2022031303024320000_B39","doi-asserted-by":"crossref","first-page":"e1501257","DOI":"10.1126\/sciadv.1501257","article-title":"Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response","volume":"2","author":"Ghari","year":"2016","journal-title":"Sci Adv"},{"key":"2022031303024320000_B40","doi-asserted-by":"crossref","first-page":"101060","DOI":"10.1016\/j.molmet.2020.101060","article-title":"Purification of pancreatic endocrine subsets reveals increased iron metabolism in beta cells","volume":"42","author":"Berthault","year":"2020","journal-title":"Mol Metab"},{"key":"2022031303024320000_B41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.chembiol.2018.03.002","article-title":"The rheumatoid arthritis-associated citrullinome","volume":"25","author":"Tilvawala","year":"2018","journal-title":"Cell Chem Biol"},{"key":"2022031303024320000_B42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/dmrr.256","article-title":"Serum IFN-\u03b3 and IL-10 levels are associated with disease progression in non-obese diabetic mice","volume":"18","author":"Schloot","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031303024320000_B43","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2337\/db12-1345","article-title":"Reduction of circulating neutrophils precedes and accompanies type 1 diabetes","volume":"62","author":"Valle","year":"2013","journal-title":"Diabetes"},{"key":"2022031303024320000_B44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat Med"},{"key":"2022031303024320000_B45","doi-asserted-by":"crossref","first-page":"e2836","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell Death Dis"},{"key":"2022031303024320000_B46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11892-008-0019-9","article-title":"T cells in the pathogenesis of type 1 diabetes","volume":"8","author":"Mallone","year":"2008","journal-title":"Curr Diab Rep"},{"key":"2022031303024320000_B47","doi-asserted-by":"crossref","first-page":"e129687","DOI":"10.1172\/jci.insight.129687","article-title":"Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination","volume":"4","author":"Sun","year":"2019","journal-title":"JCI Insight"},{"key":"2022031303024320000_B48","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1021\/acs.jmedchem.7b00274","article-title":"Development of a selective inhibitor of protein arginine deiminase 2","volume":"60","author":"Muth","year":"2017","journal-title":"J Med Chem"},{"key":"2022031303024320000_B49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nchembio.1735","article-title":"Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation","volume":"11","author":"Lewis","year":"2015","journal-title":"Nat Chem Biol"},{"key":"2022031303024320000_B50","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3390\/ijms20092174","article-title":"Discovery of novel potential reversible peptidyl arginine deiminase inhibitor","volume":"20","author":"Aliko","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db20-0421","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/70\/2\/516\/510806\/db200421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/70\/2\/516\/510806\/db200421.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:41:10Z","timestamp":1667407270000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/70\/2\/516\/39467\/Peptidylarginine-Deiminase-Inhibition-Prevents"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,17]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db20-0421","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}